First Page | Document Content | |
---|---|---|
![]() Date: 2009-12-11 09:59:33Biology Research Genomics Institute of the Novartis Research Foundation Friedrich Miescher University of Basel Ciba Syngenta Basel Institute for Immunology Medicine Novartis Friedrich Miescher Institute for Biomedical Research | Add to Reading List |
![]() | Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scientiDocID: 1rf3r - View Document |
![]() | Centre for Biomedical Genetics & Cancer Genomics Centre & CB G C G C November 10 & 11, 2011DocID: 1r5ek - View Document |
![]() | PowerPoint-Präsentation - Folie 1DocID: 1oO6J - View Document |
![]() | Institute Report 2011–2013 Max Planck Institute of Immunobiology and Epigenetics 2DocID: 1otNz - View Document |
![]() | SFB 1064 Chromatin Dynamics Seminar Marc Bühler Friedrich-Miescher-InstitutDocID: 1oelf - View Document |